Actual Medicinal Product (AMP) Clonazepam 500microgram tablets (Neuraxpharm UK Ltd)
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Anecdotal reports of use in MCAs for up to 2 weeks (low quality evidence).
- Provenance
-
This recommendation is based on the products Clonazepam 500mcg tablets (Neuraxpharm UK Ltd).
- Generic
- Clonazepam
- Formulation
- Clonazepam 500microgram tablets
-
Clonazepam
-
Clonazepam 500microgram tablets
-
Clonazepam 500microgram tablets (Neuraxpharm UK Ltd)
-
-
Clonazepam 500microgram orodispersible tablets